A declaration of rights and demand for social and political solutions from people affected by TB at the 2018 Union World Conference on Lung Health.

Activists urge the Global Fund and donors to take prompt action to address the grave risks posed to countries that are rapidly shifting from pooled procurement of TB medicines and commodities.

Activists urge international donors and country governments to ensure access to quality health products as domestic financing policies push programs to the edge of procurement cliff.

In a symbolic display, activists invited conference participants to discard the injectable agents and commit to rapidly scaling up access to safer, more effective medicine.

Provocative distribution of yellow lemonade in urine collection cups calls attention to need for this simple, urine-based test.

Activists demand that Johnson & Johnson cut the price of bedaquiline in half, to no higher than $1 per day—$32 per person per month—double the price that researchers estimate bedaquiline could be sold for a profit.

Provocative distribution of yellow lemonade in urine collection cups calls attention to need for this simple, urine-based test.

Activists ask the company to drop the price of bedaquiline in all markets to $32 a month or lower.

CAPE TOWN, 5th DECEMBER 2015: Today activists disrupted the calm halls of the 46th Union World Conference on Lung Health. Activists from the Treatment Action Campaign (TAC), SECTION27, the Global TB Community Advisory Board, the Global Coalition of TB Activists (GCTA) and the ITPC sat on the floors of the hallways and held their own plenary session in huge disappointment at the “business as usual” status quo of the Union.

TB activists at the 46th Union World Conference on Lung Health demanded that pharmaceutical company Sanofi be held accountable for failing to provide life-saving products to people and children living with TB and drug-resistant TB in South Africa and across the world.